In an Aug 29 announcement, the group says this came on the back of markets continuing to determine a new equilibrium and average selling price (ASP) of disposable examination gloves and the continued increase of ancillary products.
UG Healthcare has reported a net loss of $6.1 million in FY2024 ended June 30, improving 70.8% y-o-y from a net loss of $20.7 million in the previous financial year.
Similarly, the group narrowed its net loss in 2HFY2024 by 93.3% y-o-y to $1.08 million from $16 million in 2HFY2023.
